PF-Atlas › Clinical Trials › NCT03273387

The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension

Trimetazidine · Phase 2

Registry ID

NCT03273387

Phase

Phase 2

Status

Completed

Drug / intervention

Trimetazidine

Sponsor

Indonesia University

Start

2017-09-10

Enrollment

Locations

About this trial

The study will evaluate the effect of trimetazidine versus placebo in addition to standard pulmonary arterial hypertension regime on right ventricular function in pulmonary arterial hypertension patients.

View NCT03273387 on ClinicalTrials.gov →

Explore related

All Trimetazidine trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT03273387 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.